Suchergebnisse - "Porta, Camillo"

PubPharm (628)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

4

Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma

enthalten in: Clinical genitourinary cancer | 2024

von Grünwald, V. | Larkin, J. | Puente, J. | +2

5

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma : Insights From the ARON-1 Study

enthalten in: Clinical genitourinary cancer | 2024

von Monteiro, F. | Fiala, O. | Massari, F. | +17

6

Papillary Renal Cell Carcinoma : Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

enthalten in: European urology oncology | 2024

von Massari, F. | Mollica, V. | Fiala, O. | +21

7

Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension : A much more complicated relationship than expected

enthalten in: Cancer | 2024

von Porta, C. | Negri, F. | Cosmai, L.

8

Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib : Analysis of the Phase III TIVO-3 Trial

enthalten in: The oncologist | 2024

von Beckermann, K. | Asnis-Alibozek, A. | Atkins, M. | +8

9

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer

enthalten in: Clinical colorectal cancer | 2024

von Roazzi, L. | Patelli, G. | Bencardino, K. | +10

10

Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment : a single-center experience

enthalten in: Clinical and experimental medicine | 2024

von D'Oronzo, S. | Cives, M. | Lauricella, E. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[63]